cerrar
Tagged with clinical trials

Interview: Ciro Caravaggio, General Manager, Roche, Chile
Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. He stresses…

Interview: Ana Torres, Country Manager, Pfizer Portugal
“Although Pfizer is today one of the major contributors to Investigator-Initiated Research in Portugal in very important areas like inflammation,…

Interview: José Aranda da Silva, General Manager, Formifarma,…
José Aranda da Silva, General Manager of Formifarma Portugal, stresses the importance of market access, demonstrating added value for companies…

Interview: Endang Hoyaranda, President Director, Prodia Group,…
Endang W. Hoyaranda, President Director of Prodia Group, speaks about the ongoing challenges of clinical trials in Indonesia, especially in remote…

The future of innovation in Ireland
With budget cuts in response to the financial crisis barely touching the science sector, could it be that innovative pharmaceutical companies could…

Interview: Ming-Chu Hsu, Chairman & CEO, TaiGen…
TaiGen is on the brink of releasing Taiwan’s first innovative drug. In this interview, the Chairman and CEO of the company discusses the development…

Interview: Ellson Chen, President & CEO, Vita Genomics,…
The President & CEO of Vita Genomics talks about the advantages that genomic testing offer both to sick and healthy patients, as well as the…

Interview: Stanley Chang Chairman and CEO, Medigen Biotechnology…
The chairman and CEO of Medigen shares his insights on a significant past three years for the company, which included both an IPO and major…

Interview with Ivan Y. Zhai, CEO and Major Founder, GCP CMIC…
You are the CEO of GCP CMIC ClinPlus in addition to R&G PharmaStudies, and before that you headed a number of companies as well. Could you…

Interview with Diana Valencia, Executive Director, LatAm Clinical…
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a…

Interview with Svetlana Zavidova, Executive Director, Association…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment,…

Interview: Glenn Saldanha, Managing Director & CEO, Glenmark
Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here